Mrv1909 12021903452D 18 18 0 0 0 0 999 V2000 -1.4289 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7144 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -1.2374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7144 -1.2374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.8578 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.8578 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7144 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5723 -1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7144 1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 0.4125 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 2 0 0 0 0 2 5 2 0 0 0 0 2 6 1 0 0 0 0 3 7 1 0 0 0 0 4 8 1 0 0 0 0 5 9 1 0 0 0 0 7 10 1 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 10 13 2 0 0 0 0 12 14 1 0 0 0 0 12 15 1 0 0 0 0 14 16 1 0 0 0 0 15 17 2 0 0 0 0 16 18 1 0 0 0 0 8 9 2 0 0 0 0 M END > DB13069 > drugbank > CC1=NC=C(CNC(=O)N(CCCl)N=O)C(N)=N1 > InChI=1S/C9H13ClN6O2/c1-6-12-4-7(8(11)14-6)5-13-9(17)16(15-18)3-2-10/h4H,2-3,5H2,1H3,(H,13,17)(H2,11,12,14) > VFEDRRNHLBGPNN-UHFFFAOYSA-N > C9H13ClN6O2 > 272.69 > 272.0788514 > 5 > 31 > 25.70676164828004 > 1 > 2 > 0 > 1 > 1-[(4-amino-2-methylpyrimidin-5-yl)methyl]-3-(2-chloroethyl)-3-nitrosourea > 0.80 > 0.6260267126666659 > -3.26 > 0 > 1 > 1 > 12.944433019409894 > 6.263701786124429 > 113.57 > 68.5516 > 5 > 1 > 1.49e-01 g/l > 4-{5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1,3-benzodiazol-1-ylsulfonyl}phenoxyacetic acid > 0 > DB13069 > investigational > Nimustine > Nimustina; Nimustine; Nimustinum > Nimustine hydrochloride $$$$